Bluejay Diagnostics

BJDX · NASDAQ

$0.6705−$0.0259 (−3.72%)TodayMarket closed ·
Prev close $0.6964

Latest news

  • News

    Bluejay Diagnostics Completes Establishment Of Manufacturing Site For Symphony Cartridges, Reaching Contractual Milestone As It Advances Toward Regulatory Submission And Potential Commercialization

  • Press releaseACCESS Newswire

    Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness

  • NewsVandana Singh

    Bluejay Diagnostics Advances Rapid Biomarker Testing For Sepsis Patients

  • News

    Bluejay Diagnostics Reports SYMON-II Baseline Data Showing Diverse Critically Ill Sepsis Population And Meaningful Mortality Events Supporting IL-6 Evaluation For 28-Day Mortality Risk

  • Press releaseACCESS Newswire

    Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock

  • News

    Bluejay Diagnostics And Lovell Announce Distribution, Co-Marketing And Strategic Partnership To Support Introduction Of Bluejay’s Products Into U.S. Federal Healthcare Market

  • Press releaseGlobe Newswire

    Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets

  • Press releaseGlobe Newswire

    Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • News

    Bluejay Diagnostics Completes Patient Enrollment In SYMON-II Multicenter Clinical Validation Study

  • Press releaseGlobe Newswire

    Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

  • NewsLekha Gupta

    What's Going On With Bluejay Diagnostics Shares On Wednesday?

  • NewsVandana Singh

    Why Is Bluejay Diagnostics Stock Soaring Tuesday?

  • News

    Market-Moving News for June 2nd

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    Why Etsy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    US Stocks Mixed; Nasdaq Falls Over 50 Points

  • News

    Market-Moving News for October 9th

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • NewsAvi Kapoor

    Crude Oil Gains 1%; Walgreens Posts Upbeat Earnings

  • NewsAvi Kapoor

    Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March

  • NewsAvi Kapoor

    Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Nasdaq Surges Over 400 Points; China Pharma Shares Plummet

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • NewsAvi Kapoor

    Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.